Suchergebnisse - "Hanmant Barkate"

PubPharm (16)

1

ExPert ConsEnsus on the management of Advanced clear-cell RenaL celL carcinoma: INDIAn Perspective (PEARL-INDIA)

in: BMC Cancer | 2023

von Tarini Prasad Sahoo | Chirag Desai | Shyam Agarwal | +13

2

A Prospective, Randomized, Comparative Study of Topical Minocycline Gel 4% with Topical Clindamycin Phosphate Gel 1% in Indian Patients with Acne Vulgaris

in: Antibiotics | 2023

von Bela Shah | Deval Mistry | Nelry Gonsalves | +3

3

Use of single-inhaler triple therapy in the management of obstructive airway disease: Indian medical experts’ review

in: ERJ Open Research | 2022

von Raja Dhar | Deepak Talwar | Sundeep Salvi | +6

4

Real-world Retrospective Assessment of Initiation and Effectiveness of Dual Combination Therapy with Metformin and Teneligliptin in Drug Naïve Indian Type 2 Diabetes Mellitus Patients (INITIATE)

in: Journal of Clinical and Diagnostic Research | 2022

von Manoj Chadha | Subodh Banzal | S. Sridhar | +5

5

Comparative efficacy and safety of glycopyrronium/formoterol fixed-dose combination versus glycopyrronium monotherapy in patients with moderate-to–severe COPD

in: Lung India | 2022

von Sundeep Salvi | Manish K Jain | Srikanth Krishnamurthy | +10

6

Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin

enthalten in: BMC pharmacology & toxicology | 2021

von Dobbins, R. | Hussey, E. | O'Connor-Semmes, R. | +6

7

Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin

enthalten in: BMC pharmacology & toxicology | 2021

von Dobbins, R. | Hussey, E. | O’Connor-Semmes, R. | +6

8

Retrospective Study to Assess the Effect of Telmisartan on Urine Albumin to Creatinine Ratio in Indian Hypertensive Patients

in: European Cardiology Review | 2021

von Balram Sharma | Hanmant Barkate | Sachin Suryawanshi | +3

9

Response to the comments received on article “Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial” by Udwadia et al

in: International Journal of Infectious Diseases | 2021

von Zarir F. Udwadia | Hanmant Barkate | Saiprasad Patil | +4

10

Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial

in: International Journal of Infectious Diseases | 2021

von Zarir F. Udwadia | Pawan Singh | Hanmant Barkate | +7